Endo International PLC (ENDP)

Add to Watchlists
Create an Alert
3.93 +0.02  +0.51% NASDAQ Jun 18, 09:37 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/08/2019 09:00 EDT Misc Endo International PLC Second Quarter Earnings Conference Call in 2019
08/08/2019 Earnings Endo International PLC Second Quarter Earnings in 2019 Release
06/11/2019 Misc Endo International PLC Annual General Meeting in 2018
05/09/2019 07:30 EDT Misc Endo International PLC First Quarter Earnings Conference Call in 2019
05/09/2019 Earnings Endo International PLC First Quarter Earnings in 2019 Release
02/28/2019 07:30 EST Misc Endo International PLC Fourth Quarter Earnings Conference Call in 2018
02/28/2019 Earnings Endo International PLC Fourth Quarter Earnings in 2018 Release
02/28/2019 Misc Endo International PLC Annual Report in 2018
11/08/2018 08:00 EST Misc Endo International PLC Third Quarter Earnings Conference Call in 2018
11/08/2018 Earnings Endo International PLC Third Quarter Earnings Results in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.endo.com
  • Investor Relations URL: http://www.endo.com/investors/overview
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 08, 2019
  • Last Earnings Release: May. 09, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: After a string of acquisitions and divestitures, Endo is a specialty pharmaceutical company with a considerable presence in pain management. The acquisitions of Auxilium and Par increased the company's presence in urology and generics, respectively.

Top Fund Holders

Symbol Name Weighting
CHO204 Chou Europe Class F 9.92%
CHOEX Chou Opportunity 4.63%
MVISX Miller Opportunity IS 2.91%
CHO104 Chou Associates Class F 2.78%
LHVIX Linde Hansen Contrarian Value I 1.86%
XPH SPDR® S&P Pharmaceuticals ETF 1.48%
DROCX Diamond Hill Research Opportunities C 1.42%
PPH VanEck Vectors Pharmaceutical ETF 0.39%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("ENDP","name")
  • Description: =YCI("ENDP","description")
  • Sector: =YCI("ENDP","sector")
  • Industry: =YCI("ENDP","industry")
  • Est. Current Fiscal Year End: =YCI("ENDP","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.